Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hydroxyurea induced hepatitis

R Heddle, A F Calvert

The Medical Journal of Australia

|February 9, 1980

Summary

This summary is machine-generated.

Hydroxyurea therapy can cause self-limited hepatitis and influenza-like symptoms. These reactions resolved upon drug discontinuation and recurred upon reintroduction, confirming the drug

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluation of outcome after cardiomyotomy for achalasia using the Chicago classification.

The British journal of surgery·2016

Same author

Impaired bolus clearance in asymptomatic older adults during high-resolution impedance manometry.

Neurogastroenterology and motility·2016

Same author

Maximum upper esophageal sphincter (UES) admittance: a non-specific marker of UES dysfunction.

Neurogastroenterology and motility·2015

Same author

Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies.

Allergy·2013

Same author

Swallowing dysfunction in healthy older people using pharyngeal pressure-flow analysis.

Neurogastroenterology and motility·2013

Same author

Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants' allergies in first year of life: randomised controlled trial.

BMJ (Clinical research ed.)·2012

Same journal

Four Urgent Actions for the Rights to Culturally Safe Breastfeeding for Aboriginal and Torres Strait Islander Mothers and Babies to Breastfeed in Neonatal Intensive Care Environments.

The Medical journal of Australia·2026

Same journal

Intergenerational Child Protection Contact and Child Development Outcomes: A Whole Population Linked Data Study.

The Medical journal of Australia·2026

Same journal

Treatment and Survival Outcomes for Indigenous and Non-Indigenous Australians Within the Victorian Lung Cancer Registry: A Retrospective Cross-Sectional Cohort Study.

The Medical journal of Australia·2026

Same journal

Worsening Asthma Outcomes in Australian Adults: A Comparison of Stratified Sample Surveys in 2012 and 2021.

The Medical journal of Australia·2026

Same journal

Stigmatising Attitudes Towards People With Depression, Bipolar Disorder, Borderline Personality, ADHD and Early and Long-Term/Untreated Schizophrenia: Representative Survey of Australian Adults.

The Medical journal of Australia·2026

Same journal

Continuity of Care in General Practice in Australia: A Whole-Of-Population Serial Cross-Sectional Study.

The Medical journal of Australia·2026

See all related articles

Area of Science:

Hepatology
Pharmacology
Clinical Medicine

Background:

Hydroxyurea is a medication used to treat myeloproliferative neoplasms and sickle cell disease.
Drug-induced liver injury (DILI) is a significant concern in clinical practice.

Observation:

A patient presented with symptoms suggestive of hepatitis and an influenza-like illness during hydroxyurea therapy.
The patient experienced a recurrence of these symptoms upon rechallenge with hydroxyurea.

Findings:

The clinical presentation and recurrence pattern strongly suggest hydroxyurea-induced self-limited hepatitis.
The influenza-like reaction is also attributed to hydroxyurea exposure.

Implications:

This case highlights the potential for hydroxyurea to cause hepatotoxicity and systemic inflammatory responses.

Related Experiment Videos

Clinicians should consider hydroxyurea-induced liver injury in patients presenting with compatible symptoms.

Awareness of this adverse effect profile is crucial for patient monitoring and management during hydroxyurea treatment.